Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-10-20
1990-07-10
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 536 53, 536 551, A61K 3170
Patent
active
049406949
ABSTRACT:
A pharmaceutical preparation containing the ganglio-side GM.sub.1 or an inner ester derivative thereof and a method for increasing cerebral blood flow in stroke victims by acute administration of GM.sub.1 or its inner ester derivative.
REFERENCES:
patent: 4415733 (1983-11-01), Tayot
patent: 4435389 (1984-03-01), Mutai et al.
patent: 4476119 (1984-10-01), Valle et al.
patent: 4521593 (1985-06-01), Martin
patent: 4631294 (1986-12-01), Barsan
Maladies et Medicaments/Drugs and Diseases 1984, vol. 1, No. 3, 44-53, Borzeix.
Journal of Neuroscience Research 12:493-498 (1984), S. Bassi et al.
Clinical Neuropharmacology, vol. 7, Suppl. 1, 1984, M. Reivich et al.
Gangliosides and Neuronal Plasticity, Fidia Research Series, vol. 6, Liviana Press, Padova (1986), pp. 435-443, Cahn et al.
Journal of Neuroscience Research 12:397-408 (1984), Toffano et al.
Cerebrovascular Diseases, 1981, F. Plum.
Eur. Neurol. 24:343-351 (1985), Battistin et al.
Neurology, vol. 22, Apr. 1972, pp. 377-383, Patten et al.
Nature, vol. 323, 9 Oct. 1986, Sabel et al.
Science, vol. 225, pp. 340-341.
Dev. Neurosci. 6:73-100 (1983/84), Varon et al.
Prog. Clin. Biol. Res. 79 (1982), Varon et al.
Minerva Medica, 66, 3774-3784 (1985), Lipparini et al.
Journal of Neuroscience Research 7:363-370 (1982), Domanska-Janik et al.
Chemical Abstracts 89:213206w, Mirzoyan et al.
Chemical Abstracts 89:1066a, Sekoyan.
Adv. Exp. Med. Biol. 174, 593-600 (1984), Horowitz.
della Valle Francesco
Lorenzi Silvana
Romeo Aurelio
Fidia S.p.A.
Griffin Ronald W.
LandOfFree
Therapeutic use of GM1 in severe cerebral ischemic strokes patho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of GM1 in severe cerebral ischemic strokes patho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of GM1 in severe cerebral ischemic strokes patho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1720930